Table 1.
Participant characteristics
| Non-randomised patients (n=61) | Randomised patients (n=27) | EORTC cohort*(n=540) | |
|---|---|---|---|
| Age, years | |||
| Mean (SD) | 73·07 (8·87) | 65·74 (7·22) | 65·54 (7·48) |
| Median (IQR) | 74 (67–80) | 65 (61–71) | 65 (59–72) |
| Sex | |||
| Female | 22 (36%) | 8 (30%) | 269 (50%) |
| Male | 39 (64%) | 19 (70%) | 271 (50%) |
| Charlson Comorbidity Index | |||
| 0 | 16 (26%) | 14 (52%) | .. |
| 1 | 6 (10%) | 4 (15%) | .. |
| 2 | 19 (31%) | 3 (11%) | .. |
| 3 | 4 (7%) | 2 (7%) | .. |
| 4 | 1 (2%) | 0 | .. |
| 5 | 3 (5%) | 1 (4%) | .. |
| 6 | 3 (5%) | 0 | .. |
| 7 | 0 | 1 (4%) | .. |
| Missing data | 9 (15%) | 2 (7%) | .. |
| American Society of Anesthesiologists grade | |||
| 1 | 24 (39%) | 11 (41%) | .. |
| 2 | 23 (38%) | 14 (52%) | .. |
| 3 | 13 (21%) | 2 (7%) | .. |
| Missing data | 1 (2%) | 0 | .. |
| Any comorbidities | |||
| No | .. | .. | 345 (34%) |
| Yes | .. | .. | 589 (59%) |
| Prefer not to answer | .. | .. | 70 (7%) |
| Missing data | .. | .. | 2 (<1%) |
Data are n (%) unless otherwise indicated. EORTC=European Organisation for Research and Treatment of Cancer.
*
Data from a cohort of age-matched individuals without a cancer diagnosis from the UK general population.